We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Arthur J. Gallagher & Co
AJG
$64B
| $22K | ﹤0.01% |
+177
| New | +$20.2K |
|
827
Aon
AON
$76.1B
| $22K | ﹤0.01% |
+104
| New | +$21.2K |
|
828
American Express
AXP
$233B
| $22K | ﹤0.01% |
+178
| New | +$19.7K |
|
829
BJ's Restaurants
BJRI
$1.42B
| $22K | ﹤0.01% |
+567
| New | +$19.3K |
|
830
CME Group
CME
$95.5B
| $22K | ﹤0.01% |
+121
| New | +$20.6K |
|
831
CoreCivic
CXW
$3B
| $22K | ﹤0.01% |
+3,290
| New | +$23.7K |
|
832
Ecolab
ECL
$78.2B
| $22K | ﹤0.01% |
+103
| New | +$21.5K |
|
833
Eastman Chemical
EMN
$8.23B
| $22K | ﹤0.01% |
+222
| New | +$20.6K |
|
834
Enanta Pharmaceuticals
ENTA
$372M
| $22K | ﹤0.01% |
+532
| New | +$23.4K |
|
835
Intercontinental Exchange
ICE
$85.5B
| $22K | ﹤0.01% |
+194
| New | +$20.1K |
|
836
International Flavors & Fragrances
IFF
$20.5B
| $22K | ﹤0.01% |
+203
| New | +$22.8K |
|
|
MRSH
837
Marsh
MRSH
$92.2B
| $22K | ﹤0.01% |
+184
| New | +$20.9K |
|
838
Nasdaq
NDAQ
$52.9B
| $22K | ﹤0.01% |
+507
| New | +$21.5K |
|
839
Onto Innovation
ONTO
$13.5B
| $22K | ﹤0.01% |
+468
| New | +$18.8K |
|
840
Occidental Petroleum
OXY
$55B
| $22K | ﹤0.01% |
+1,285
| New | +$17.6K |
|
841
Corpay
CPAY
$25.2B
| $22K | ﹤0.01% |
+79
| New | +$20.3K |
|
|
JBTM
842
JBT Marel
JBTM
$7.41B
| $22K | ﹤0.01% |
+197
| New | +$20.3K |
|
|
NUVA
843
DELISTED
NuVasive, Inc.
NUVA
| $22K | ﹤0.01% |
+386
| New | +$19K |
|
844
Boot Barn
BOOT
$4.88B
| $21K | ﹤0.01% |
+495
| New | +$18.6K |
|
845
Designer Brands
DBI
$329M
| $21K | ﹤0.01% |
+2,768
| New | +$18.4K |
|
846
Ethan Allen Interiors
ETD
$594M
| $21K | ﹤0.01% |
+1,051
| New | +$18.5K |
|
847
Fulgent Genetics
FLGT
$502M
| $21K | ﹤0.01% |
+397
| New | +$16.6K |
|
848
Helen of Troy
HELE
$686M
| $21K | ﹤0.01% |
+93
| New | +$19.2K |
|
|
IRBT
849
DELISTED
iRobot
IRBT
| $21K | ﹤0.01% |
+265
| New | +$21.6K |
|
850
Jazz Pharmaceuticals
JAZZ
$15.9B
| $21K | ﹤0.01% |
+125
| New | +$18.6K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.